(CHH) Choice Hotels International - Ratings and Ratios
Hotel Franchising, Brand Licensing, Property Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.21% |
| Yield on Cost 5y | 1.16% |
| Yield CAGR 5y | 22.12% |
| Payout Consistency | 66.2% |
| Payout Ratio | 16.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Value at Risk 5%th | 44.9% |
| Relative Tail Risk | -2.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.96 |
| Alpha | -39.63 |
| CAGR/Max DD | -0.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.399 |
| Beta | 0.786 |
| Beta Downside | 0.712 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.50% |
| Mean DD | 12.99% |
| Median DD | 10.73% |
Description: CHH Choice Hotels International January 09, 2026
Choice Hotels International (CHH) is a global hotel franchisor that licenses a portfolio of 20+ brands-including Comfort Inn, Ascend Hotel Collection, and Radisson-to independent owners, operating through two reporting segments: Hotel Franchising & Management and Corporate & Other.
In FY 2024 the company reported a 7.2% year-over-year increase in franchise fee revenue, driven by a 4.5% rise in system-wide rooms and a 3.1% lift in average daily rate (ADR). Its RevPAR growth of 5.8% outpaced the industry median of 3.9%, reflecting strong brand-level performance and a growing pipeline of over 1,200 new openings slated through 2026.
Key macro drivers include U.S. consumer confidence, which remains above 100 (April 2024), supporting leisure travel demand, and a gradual easing of inflationary pressure that benefits discretionary spending on accommodations. Conversely, higher interest rates could temper new franchise development, adding upside uncertainty to the franchise fee outlook.
For a deeper, data-rich analysis of CHH’s valuation dynamics, consider exploring the detailed metrics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (382.1m TTM) > 0 and > 6% of Revenue (6% = 95.8m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 1.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.14% (prev -9.02%; Δ 7.88pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 267.6m <= Net Income 382.1m (YES >=105%, WARN >=100%) |
| Net Debt (1.98b) to EBITDA (637.4m) ratio: 3.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.5m) change vs 12m ago -1.56% (target <= -2.0% for YES) |
| Gross Margin 51.46% (prev 48.30%; Δ 3.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 58.57% (prev 61.06%; Δ -2.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.43 (EBITDA TTM 637.4m / Interest Expense TTM 88.5m) >= 6 (WARN >= 3) |
Altman Z'' 4.77
| (A) -0.01 = (Total Current Assets 450.3m - Total Current Liabilities 468.5m) / Total Assets 2.91b |
| (B) 0.78 = Retained Earnings (Balance) 2.27b / Total Assets 2.91b |
| (C) 0.21 = EBIT TTM 569.5m / Avg Total Assets 2.73b |
| (D) 0.82 = Book Value of Equity 2.26b / Total Liabilities 2.76b |
| Total Rating: 4.77 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.81
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.01% |
| 3. FCF Margin 13.19% |
| 4. Debt/Equity 13.54 |
| 5. Debt/Ebitda 3.10 |
| 6. ROIC - WACC (= 19.45)% |
| 7. RoE data missing |
| 8. Rev. Trend 57.31% |
| 9. EPS Trend -7.82% |
What is the price of CHH shares?
Over the past week, the price has changed by -4.03%, over one month by +7.73%, over three months by +5.35% and over the past year by -27.07%.
Is CHH a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 9
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the CHH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 106.7 | 2.5% |
| Analysts Target Price | 106.7 | 2.5% |
| ValueRay Target Price | 100 | -3.9% |
CHH Fundamental Data Overview January 15, 2026
P/E Forward = 15.1976
P/S = 6.1192
P/B = 33.0483
P/EG = 1.519
Revenue TTM = 1.60b USD
EBIT TTM = 569.5m USD
EBITDA TTM = 637.4m USD
Long Term Debt = 1.92b USD (from longTermDebt, last quarter)
Short Term Debt = 5.37m USD (from shortTermDebt, last fiscal year)
Debt = 2.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 6.99b USD (5.02b + Debt 2.03b - CCE 52.6m)
Interest Coverage Ratio = 6.43 (Ebit TTM 569.5m / Interest Expense TTM 88.5m)
EV/FCF = 33.21x (Enterprise Value 6.99b / FCF TTM 210.5m)
FCF Yield = 3.01% (FCF TTM 210.5m / Enterprise Value 6.99b)
FCF Margin = 13.19% (FCF TTM 210.5m / Revenue TTM 1.60b)
Net Margin = 23.93% (Net Income TTM 382.1m / Revenue TTM 1.60b)
Gross Margin = 51.46% ((Revenue TTM 1.60b - Cost of Revenue TTM 774.9m) / Revenue TTM)
Gross Margin QoQ = 53.49% (prev 53.39%)
Tobins Q-Ratio = 2.40 (Enterprise Value 6.99b / Total Assets 2.91b)
Interest Expense / Debt = 1.16% (Interest Expense 23.5m / Debt 2.03b)
Taxrate = 14.66% (30.9m / 210.9m)
NOPAT = 486.0m (EBIT 569.5m * (1 - 14.66%))
Current Ratio = 0.96 (Total Current Assets 450.3m / Total Current Liabilities 468.5m)
Debt / Equity = 13.54 (Debt 2.03b / totalStockholderEquity, last quarter 149.8m)
Debt / EBITDA = 3.10 (Net Debt 1.98b / EBITDA 637.4m)
Debt / FCF = 9.38 (Net Debt 1.98b / FCF TTM 210.5m)
Total Stockholder Equity = 3.58m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.02% (Net Income 382.1m / Total Assets 2.91b)
RoE = 10.7k% (out of range, set to none) (Net Income TTM 382.1m / Total Stockholder Equity 3.58m)
RoCE = 29.63% (EBIT 569.5m / Capital Employed (Equity 3.58m + L.T.Debt 1.92b))
RoIC = 26.00% (NOPAT 486.0m / Invested Capital 1.87b)
WACC = 6.56% (E(5.02b)/V(7.04b) * Re(8.81%) + D(2.03b)/V(7.04b) * Rd(1.16%) * (1-Tc(0.15)))
Discount Rate = 8.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.14%
[DCF Debug] Terminal Value 80.61% ; FCFF base≈179.9m ; Y1≈143.4m ; Y5≈96.4m
Fair Price DCF = 10.24 (EV 2.45b - Net Debt 1.98b = Equity 473.8m / Shares 46.3m; r=6.56% [WACC]; 5y FCF grow -24.27% → 2.90% )
EPS Correlation: -7.82 | EPS CAGR: -42.35% | SUE: -4.0 | # QB: 0
Revenue Correlation: 57.31 | Revenue CAGR: 12.81% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.30 | Chg30d=-0.016 | Revisions Net=-1 | Analysts=8
EPS next Year (2026-12-31): EPS=7.09 | Chg30d=-0.069 | Revisions Net=-2 | Growth EPS=+2.5% | Growth Revenue=+2.0%
Additional Sources for CHH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle